BioSpace News Archive

PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care.

DDF celebrated its distinguished Board of Directors, welcomed new Board members, and recognized major contributors to its mission.

MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced the release of MMPower v4, the latest update to its Clinical Decision Support platform

CNSI, a leading business solutions provider in developing and delivering innovative health information technology solutions, announced today that David Adams has joined the company as Executive Vice President and Chief Financial Officer (CFO)

The Exogenesis Hernia Mesh is indicated for the repair of abdominal wall hernias and abdominal wall deficiencies that require the addition of reinforcing material to obtain the desired surgical result

AODocs for Life Sciences helps companies achieve FDA compliance

ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced it completed $15 million in financing and that medical device industry veterans Ryan Drant and Tim Patrick have joined its board of directors.

Accudata Systems, Inc., and Solis Mammography today announced their strategic partnership has led to the development of Center-in-a-Box, a scalable and cost-predictable technology solution that supports the rapid deployment of breast screening and diagnostic services across the United States.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced 95% year over year order growth for the third quarter 2019.

Preventice Solutions announced today it received a tender from the UK Biobank to provide the BodyGuardian® MINI remote cardiac monitor for a cardiovascular monitoring study involving up to 30,000 participants